EB-0156 is a potent inhibitor of ER alpha-glucosidases (alpha-Glu) Iand II with IC50s of 0.0479 and less than 0.001 µM, respectively. EB-0156 is a N-substituted derivative of valiolamine with broad-spectrum antiviral. EB-0156 has the potential for the reseach of broad-spectrum agent against the existing and emerging viruses[1].
Molekulargewicht:
480.51
CAS Nummer:
[2832824-43-6]
Formel:
C21H32N6O7
Target-Kategorie:
Glycosidase
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
